China coronavirus vaccine may be ready for public in November: official

Published September 15, 2020
A box for a Covid-19 vaccine is displayed at an exhibit by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services in Beijing on September 5. —  AP/File
A box for a Covid-19 vaccine is displayed at an exhibit by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services in Beijing on September 5. — AP/File

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.

China has four Covid-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential workers under an emergency use programme launched in July.

Phase 3 clinical trials were proceeding smoothly and the vaccines could be ready for the general public in November or December, CDC chief biosafety expert Guizhen Wu said in an interview with state TV late on Monday.

Read: China displays Covid-19 vaccines for first time

Wu, who said she has experienced no abnormal symptoms in recent months after taking an experimental vaccine herself in April, did not specify which vaccines she was referring to.

A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and US-listed Sinovac Biotech are developing the three vaccines under the state's emergency use programme. A fourth Covid-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.

Sinopharm said in July that its vaccine could be ready for public use by the end of this year after the conclusion of Phase 3 trials.

Global vaccine makers are racing to develop an effective vaccine against the virus which has killed more than 928,000 people. Leading Western vaccine makers pledged earlier this month to uphold scientific study standards and reject any political pressure to rush the process.

Opinion

Back to governance

Back to governance

While PDM has continued efforts to mount political pressure, it has been unable to force a crisis to challenge the PTI government.
Inequality virus
25 Jan 2021

Inequality virus

An Oxfam report calls for radical changes to the economic system.

Editorial

Updated 25 Jan 2021

Where the buck stops

The rights to due process and security of person are accorded to every individual in this country.
25 Jan 2021

PPP’s plan?

THE PDM faces a fresh crisis as the PPP takes a conspicuously soft position on the long march. While the PDM talks ...
25 Jan 2021

Forward guidance

THE State Bank has taken the unusual step of issuing a forward guidance in its latest monetary policy statement to...
Updated 24 Jan 2021

Delayed olive branch

THE PTI government has finally mustered up sufficient political prudence to extend an olive branch to the opposition...
24 Jan 2021

Bureaucracy reform

WHILE the intention behind the endeavour may be lauded, the civil service reform package unveiled by the government...
24 Jan 2021

Minority rights

ON Thursday, the United Nations General Assembly adopted a resolution to safeguard religious sites around the world,...